Clinical Study
Combined Phacoemulsification and Intravitreal Dexamethasone Implant (Ozurdex®) in Diabetic Patients with Coexisting Cataract and Diabetic Macular Edema
Figure 1
Boxplot of central retinal thickness (CRT) (μm) over 90 days. Mean CRT significantly decreased (), mainly at 60 days after combined approach.